PT-141 10mg research peptide vial

PT-141

£38.99
£38.99
Skip to product information
PT-141 10mg research peptide vial
  • PT-141 10mg research peptide vial
  • PT-141 10mg research peptide vial
PT-141

PT-141

£38.99
£38.99

PT-141 is the development name for bremelanotide, a melanocortin-receptor agonist acting primarily at MC3R and MC4R in the central nervous system, supplied here as a 10 mg vial of lyophilised powder tested to ≥99.8% purity by HPLC analysis. A bremelanotide-containing pharmaceutical, marketed under a different brand name, has received regulatory approval for a specific indication in a defined patient population — that approval does not extend to this research-grade material. Reliable Research Labs supplies PT-141 from the UK strictly for qualified laboratory research — see "About PT-141 (Bremelanotide)" below for further background.
Not Intended for Human or Animal Consumption
View Certificate of Analysis (COA)

PRODUCT SPECIFICATIONS

  • Quantity: 10 mg
  • Appearance: Lyophilized (Freeze-Dried) Powder
  • Purity: ≥99.8% (Confirmed by HPLC Analysis)

RESEARCH USE

This material is supplied exclusively for laboratory-based, in vitro research conducted by qualified professionals. It is not approved for use in humans or animals and must not be incorporated into pharmaceuticals, dietary supplements, food products, cosmetics, or diagnostic applications.

IMPORTANT NOTICE

This product has not been reviewed or approved by the U.S. Food and Drug Administration (FDA). No claims are made regarding safety, efficacy, or therapeutic benefit. It is not intended to diagnose, treat, cure, or prevent any medical condition. Researchers are responsible for ensuring all work complies with applicable laws, regulations, and institutional protocols.

PURCHASE AGREEMENT

By completing a purchase, the customer confirms that they are a qualified researcher, laboratory, educational institution, or authorized organization purchasing this product solely for lawful research purposes. The purchaser accepts full responsibility for the proper storage, handling, use, and disposal of the product, as well as compliance with all applicable local, state, and federal regulations. All sales are considered final unless otherwise stated.

About PT-141 (Bremelanotide)

PT-141 is the development name originally used by Palatin Technologies for the compound now known by the international nonproprietary name bremelanotide — PT-141 and bremelanotide refer to the same molecule, with PT-141 being the earlier research-stage designation.

Bremelanotide is a melanocortin-receptor agonist, acting primarily at MC3R and MC4R receptors within the central nervous system. This distinguishes its proposed mechanism from peripheral vasodilator drugs such as PDE5 inhibitors, which work through a different pathway entirely.

A bremelanotide-containing pharmaceutical, marketed under a different brand name, has received regulatory approval in the United States for a specific indication in a defined patient population. This approval applies to that specific licensed pharmaceutical product and indication — it does not extend to, or imply approval of, research-grade PT-141 material supplied for laboratory use, including this product, and this product is not that licensed pharmaceutical.

Reliable Research Labs supplies PT-141 as a 10 mg vial of lyophilised powder, tested to ≥99.8% purity by HPLC analysis, strictly for qualified laboratory research. See our Compound Library entry for PT-141 for a wider overview.

What Effects of PT-141 Are Studied?

PT-141/bremelanotide has been studied in clinical research for its effect on sexual desire and arousal, acting centrally via melanocortin-receptor signalling rather than through the peripheral vascular mechanisms associated with PDE5-inhibitor medications. Published clinical trials have examined this mechanism in both male and female study populations, with the compound's approved pharmaceutical use specifically concerning a defined indication in premenopausal women.

This clinical evidence relates to a licensed pharmaceutical formulation, studied under controlled trial conditions in specific patient populations — it describes findings from that research context, not a guaranteed outcome from this research-grade product, which has not itself been tested in those trials.

Earlier development-stage research, under the PT-141 name, also examined melanocortin-receptor activity more broadly within CNS signalling pathways relevant to sexual-function research.

Reliable Research Labs supplies PT-141 exclusively for qualified laboratory research. Nothing on this page describes, recommends or implies dosing, administration, or an outcome from using this specific product, and nothing here should be read as advice about treating any sexual-function condition, or a promise of increased libido, improved arousal, or enhanced sexual performance.

Customer Reviews

You may also like